BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33441793)

  • 1. Tick saliva-induced programmed death-1 and PD-ligand 1 and its related host immunosuppression.
    Sajiki Y; Konnai S; Ikenaka Y; Gulay KCM; Kobayashi A; Parizi LF; João BC; Watari K; Fujisawa S; Okagawa T; Maekawa N; Logullo C; da Silva Vaz I; Murata S; Ohashi K
    Sci Rep; 2021 Jan; 11(1):1063. PubMed ID: 33441793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E
    Sajiki Y; Konnai S; Okagawa T; Nishimori A; Maekawa N; Goto S; Ikebuchi R; Nagata R; Kawaji S; Kagawa Y; Yamada S; Kato Y; Nakajima C; Suzuki Y; Murata S; Mori Y; Ohashi K
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29483289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of cells expressing PD-1 and PD-L1 and enhancement of IFN-γ production via PD-1/PD-L1 blockade in bovine mycoplasmosis.
    Goto S; Konnai S; Okagawa T; Nishimori A; Maekawa N; Gondaira S; Higuchi H; Koiwa M; Tajima M; Kohara J; Ogasawara S; Kato Y; Suzuki Y; Murata S; Ohashi K
    Immun Inflamm Dis; 2017 Sep; 5(3):355-363. PubMed ID: 28544524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the PD-1/PD-L1 axis in macrophage differentiation and function during pregnancy.
    Zhang Y; Ma L; Hu X; Ji J; Mor G; Liao A
    Hum Reprod; 2019 Jan; 34(1):25-36. PubMed ID: 30500923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of PD-L1 Expression by Prostaglandin E
    Goto S; Konnai S; Hirano Y; Kohara J; Okagawa T; Maekawa N; Sajiki Y; Watari K; Minato E; Kobayashi A; Gondaira S; Higuchi H; Koiwa M; Tajima M; Taguchi E; Uemura R; Yamada S; Kaneko MK; Kato Y; Yamamoto K; Toda M; Suzuki Y; Murata S; Ohashi K
    Front Vet Sci; 2020; 7():12. PubMed ID: 32154274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Immunotherapeutic Efficacy of Anti-PD-L1 Antibody in Combination with an EP4 Antagonist.
    Sajiki Y; Konnai S; Cai Z; Takada K; Okagawa T; Maekawa N; Fujisawa S; Kato Y; Suzuki Y; Murata S; Ohashi K
    Immunohorizons; 2020 Dec; 4(12):837-850. PubMed ID: 33443026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive glia promote development of CD103
    Prasad S; Hu S; Sheng WS; Chauhan P; Lokensgard JR
    Immun Inflamm Dis; 2018 Jun; 6(2):332-344. PubMed ID: 29602245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1 and PD-L1 expression on T-cell subsets in women with unexplained recurrent pregnancy losses.
    Wang WJ; Salazar Garcia MD; Deutsch G; Sung N; Yang X; He Q; Jubiz G; Bilal M; Dambaeva S; Gilman-Sachs A; Beaman K; Kwak-Kim J
    Am J Reprod Immunol; 2020 May; 83(5):e13230. PubMed ID: 32086851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed death-ligand 1 expression in swine chronic infections and enhancement of interleukin-2 production via programmed death-1/programmed death-ligand 1 blockade.
    Ganbaatar O; Konnai S; Okagawa T; Nojima Y; Maekawa N; Ichikawa Y; Kobayashi A; Shibahara T; Yanagawa Y; Higuchi H; Kato Y; Suzuki Y; Murata S; Ohashi K
    Immun Inflamm Dis; 2021 Dec; 9(4):1573-1583. PubMed ID: 34414683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed death-1
    Singh A; Mohan A; Dey AB; Mitra DK
    Clin Exp Immunol; 2017 Feb; 187(2):269-283. PubMed ID: 27665733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of programmed death-1 (PD-1) and its ligand PD-L1 is upregulated in endometriosis and promoted by 17beta-estradiol.
    Wu L; Lv C; Su Y; Li C; Zhang H; Zhao X; Li M
    Gynecol Endocrinol; 2019 Mar; 35(3):251-256. PubMed ID: 30325236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of cutaneous inflammation induced by ticks in contrasting phenotypes of infestation in bovines.
    Carvalho WA; Franzin AM; Abatepaulo AR; de Oliveira CJ; Moré DD; da Silva JS; Ferreira BR; de Miranda Santos IK
    Vet Parasitol; 2010 Feb; 167(2-4):260-73. PubMed ID: 19836891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression of Human Adipose-Derived Stem Cells on T Cell Subsets via the Reduction of NF-kappaB Activation Mediated by PD-L1/PD-1 and Gal-9/TIM-3 Pathways.
    Zhou K; Guo S; Tong S; Sun Q; Li F; Zhang X; Qiao Y; Liang G
    Stem Cells Dev; 2018 Sep; 27(17):1191-1202. PubMed ID: 29978730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between PD-1/PD-L1 and T regulate cells in early recurrent miscarriage.
    Li G; Lu C; Gao J; Wang X; Wu H; Lee C; Xing B; Zhang Q
    Int J Clin Exp Pathol; 2015; 8(6):6512-8. PubMed ID: 26261529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality.
    Saha A; O'Connor RS; Thangavelu G; Lovitch SB; Dandamudi DB; Wilson CB; Vincent BG; Tkachev V; Pawlicki JM; Furlan SN; Kean LS; Aoyama K; Taylor PA; Panoskaltsis-Mortari A; Foncea R; Ranganathan P; Devine SM; Burrill JS; Guo L; Sacristan C; Snyder NW; Blair IA; Milone MC; Dustin ML; Riley JL; Bernlohr DA; Murphy WJ; Fife BT; Munn DH; Miller JS; Serody JS; Freeman GJ; Sharpe AH; Turka LA; Blazar BR
    J Clin Invest; 2016 Jul; 126(7):2642-60. PubMed ID: 27294527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment.
    Tsukamoto H; Fujieda K; Miyashita A; Fukushima S; Ikeda T; Kubo Y; Senju S; Ihn H; Nishimura Y; Oshiumi H
    Cancer Res; 2018 Sep; 78(17):5011-5022. PubMed ID: 29967259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The blockade of PD-1/PD-L1 pathway promotes the apoptosis of CD19
    Wang Z; Tan F
    Scand J Immunol; 2020 Feb; 91(2):e12836. PubMed ID: 31598989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
    Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
    J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.
    Homma S; Hayashi K; Yoshida K; Sagawa Y; Kamata Y; Ito M
    Int Immunopharmacol; 2018 Jan; 54():39-45. PubMed ID: 29100036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Checkpoint Inhibition Followed by Tumor Infiltration of Dendritic Cells in Murine Neuro-2a Neuroblastoma.
    Inoue S; Horiuchi Y; Setoyama Y; Takeuchi Y; Beck Y; Murakami T; Odaka A
    J Surg Res; 2020 Sep; 253():201-213. PubMed ID: 32380346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.